MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Pattern of cerebral perfusion in early de novo Parkinson’s disease with mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging

    L. Jin, J. Wang, Y. Zhang, C. Wang, T. He (Shanghai, China)

    Objective: We aimed to investigate the patterns of cerebral perfusion in early de novo Parkinson’s disease (PD) patients with different cognitive states and to determine…
  • MDS Virtual Congress 2020

    Sex-associated difference in the presentation and progression of Parkinson’s disease

    H. Iwaki, C. Blauwendraat, M. Nalls, A. Singleton (Glen Echo, MD, USA)

    Objective: Identifying the contribution of sex to the heterogeneity in presentation and progression of Parkinson’s disease (PD). Background: The different prevalence of Parkinson’s disease (PD)…
  • MDS Virtual Congress 2020

    Brain activity underpinning visual cues for gait impairment in Parkinson’s disease

    S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)

    Objective: To examine brain activity when walking with and without visual cues in Parkinson’s disease (PD). Background: Gait impairments and Freezing of Gait (FOG) in…
  • MDS Virtual Congress 2020

    Predictors of the progression of dementia with Lewy bodies

    A. Chimagomedova, O. Levin (Moscow, Russian Federation)

    Objective: To define predictors of the progression of dementia with Lewy bodies (DLB). Background: Dementia with Lewy bodies is a progressive disabling neurodegenerative disease with…
  • MDS Virtual Congress 2020

    Progression of cortical thinning and neuropsychological decline in isolated Rapid Eye Movement sleep behavior disorder

    A. Inguanzo, B. Segura, A. Campabadal, A. Abos, C. Uribe, M. Serradell, C. Gaig, J. Santamaria, Y. Compta, C. Junque, A. Iranzo (Barcelona, Spain)

    Objective: We aimed to investigate the progression over time of cortical thickness and cognitive functions in isolated REM-sleep behaviour disorder (IRBD) compared to healthy controls (HC).…
  • MDS Virtual Congress 2020

    Can clinical outputs predict BDNF levels in people with Parkinson’s disease?

    M. Delabary, E. Monteiro, A. Fagundes, M. Casal, A.P Zanardi, F. Boeno, S. Munhoz, R. de Menezes, A. de Oliveira, F. Martinez, L.A Tartaruga, A. Haas (Porto Alegre, Brazil)

    Objective: To modelling the relationship between Brain-Derived Neurotrophic Factor (BDNF) levels and clinical variables (stages of disease and cognition) in people with Parkinson's disease (PD).…
  • MDS Virtual Congress 2020

    Object and action naming test in cognitive subtypes in nondemented patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to identify more homogenous profiles of patients with Parkinson´s disease (PD) without cognitive decline and to compare language…
  • MDS Virtual Congress 2020

    Clinical outcomes after DBS surgery in cognitively impaired patients with PD

    M. Patel, E. Staikova, D. Loring, M. DeLong, S. Triche, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, C. Buetefisch, S. Miocinovic (Atlanta, GA, USA)

    Objective: To describe clinical outcomes after DBS in patients with PD and moderate cognitive impairment (CI). Background: DBS is generally contraindicated in PD patients with…
  • MDS Virtual Congress 2020

    Early cognitive impairment is associated with specific regional cholinergic denervation in Parkinson’s disease

    S. vander Zee, J. Boertien, M. Gerritsen, J. Spikman, T. van Laar (Groningen, Netherlands)

    Objective: To evaluate regional cholinergic correlates of cognitive impairment in newly diagnosed, treatment-naïve Parkinson’s disease (PD) patients. Background: Mild cognitive impairment (PD-MCI) is a common…
  • MDS Virtual Congress 2020

    Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

    Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley